Use and misuse of opioids in maine: Results from pharmacists, the prescription monitoring, and the diversion alert programs

Journal of Studies on Alcohol and Drugs

Volumn 77, Issue 4, 2016, Pages 556-565

  Piper, Brian J ^a,b,c   Desrosiers, Clare E ^d   Lipovsky, John W ^e   Rodney, Matthew A ^c   Baker, Robert P ^c   McCall, Kenneth L ^f   Nichols, Stephanie D ^c,g   Martin, Sarah L ^c  

^a BOWDOIN COLLEGE   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c HUSSON UNIVERSITY   (United States)

^d Diversion Alert ^*  (United States)

^e Maine Office of Substance Abuse   (United States)

^f UNIVERSITY OF NEW ENGLAND   (United States)

^g MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; CHILD; DRUG DATABASE; FEMALE; HUMAN; MAINE; MALE; MIDDLE AGED; OFFENDER; OPIOID-RELATED DISORDERS; PHARMACIST; PHARMACY; PRESCRIPTION DRUG MISUSE; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHILD; COMMUNITY PHARMACY SERVICES; CRIMINALS; DATABASES, PHARMACEUTICAL; FEMALE; HUMANS; MAINE; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PHARMACISTS; PRESCRIPTION DRUG MISUSE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84976576456     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2016.77.556     Document Type: Article

References (51)

1. Aitken, M., Kleinrock, M., Lyle, J., Nass, D., & Caskey, L. (2015). Medicines use and spending shifts: A review of the use of medicines in the U.S. in 2014. Parsippany, NJ: IMS Institute for Healthcare Informatics. Retrieved from http://www.redaccionmedica.com/contenido/images/IIHI_Use_of_Medicines_Report_2015.pdf
2. Alexander, J. L., Burton, J. H., Bradshaw, J. R., & Colin, F. (2004). Suspected opioid-related emergency medical services encounters in a rural state, 1997-2002. Prehospital Emergency Care, 8, 427-430. doi:10.1080/312704001133
3. Boudreau, D., Von Korff, M., Rutter, C. M., Saunders, K., Ray, G. T., Sullivan, M. D., Weisner, C. (2009). Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiology & Drug Safety, 18, 1166-1175. doi:10.1002/pds.1833
4. Brown, M. S., Hayes, M. J., & Thornton, L. M. (2015). Methadone versus morphine for treatment of neonatal abstinence syndrome: A prospective randomized clinical trial. Journal of Perinatology, 35, 278-283. doi:10.1038/jp.2014.194
5. Calabresi, M. (2015, June 4). Why America can’t kick its painkiller problem. Time. Retrieved from http://time.com/3908648/why-america-cant-kick-its-painkiller-problem
6. Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data
7. Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014a). The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71, 821-826. doi:10.1001/jamapsychiatry.2014.366
8. Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014b). Factors contributing to the rise of buprenorphine misuse: 2008-2013. Drug and Alcohol Dependence, 142, 98-104. doi:10.1016/j.drugalcdep.2014.06.005
9. Conrad, C., Bradley, H. M., Broz, D., Buddha, S., Chapman, E. L., Galang, R. R., Duwve, J. M., & the Centers for Disease Control and Prevention (CDC). (2015). Community outbreak of HIV infection linked to injection drug use of oxymorphone - Indiana, 2015. Morbidity and Mortality Weekly Report, 64, 443-444. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6416a4.htm
10. Dyer, O. (2014). Kentucky seeks $1bn from Purdue Pharma for misrepresenting addictive potential of oxycodone. BMJ, 349, g6605. doi:10.1136/bmj.g6605
11. Fischer, B., Jones, W., Krahn, M., & Rehm, J. (2011). Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiology & Drug Safety, 20, 1269-1277. doi:10.1002/pds.2190
12. Ginley, B., Patterson, S. L., Nickerson, N., Bruno, J., & Grotton, J. (2002). Maine Board of Pharmacy strongly supports unrestricted sale of sterile syringes. Journal of the American Pharmaceutical Association, 42, Supplement 2, S24-S25. doi:10.1331/1086-5802.42.0.S24.Ginley
13. Grau, L. E., Dasgupta, N., Harvey, A. P., Irwin, K., Givens, A., Kinzly, M. L., & Heimer, R. (2007). Illicit use of opioids: Is OxyContin a “gateway drug”? American Journal on Addictions, 16, 166-173. doi:10.1080/10550490701375293
14. Haegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014). What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug and Alcohol Dependence, 145, 34-47. doi:10.1016/j.drugalcdep.2014.10.001
15. Hagemeier, N. E., Murawski, M. M., Lopez, N. C., Alamian, A., & Pack, R. P. (2014). Theoretical exploration of Tennessee community pharmacists’ perceptions regarding opioid pain reliever abuse communication. Research in Social & Administrative Pharmacy, 10, 562-575. doi:10.1016/j.sapharm.2013.07.004
16. Heimer, R., Dasgupta, N., Irwin, K. S., Kinzly, M., Harvey, A. P., Givens, A., & Grau, L. E. (2012). Chronic pain, addiction severity, and misuse of opioids in Cumberland County, Maine. Addictive Behaviors, 37, 346-349. doi:10.1016/j.addbeh.2011.11.017
17. International Narcotics Control Board. (2009). Report of the International Narcotics Control Board for 2008 (p. 20). New York, NY: United Nations. Retrieved from https://www.incb.org/documents/Publications/AnnualReports/AR2008/AR_08_English.pdf
18. International Narcotics Control Board. (2011). Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes. New York, NY: United Nations. Retrieved from http://www.unodc.org/documents/lpo-brazil/noticias/2011/03-marco/Jife/Report_of_the_Board_on_the_availability_of_controlled_substances.pdf
19. Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., & Schulenberg, J. E. (2015). Monitoring the Future national survey results on drug use: 1975-2014: Overview, key findings on adolescent drug use. Ann Arbor, MI: Institute for Social Research, The University of Michigan
20. Jones, B. (2010). Median age by state. USA Today. Retrieved from http://usatoday30.usatoday.com/news/nation/census/median-age-by-state.htm
21. Joranson, D. E., & Gilson, A. M. (2005). Drug crime is a source of abused pain medications in the United States. Journal of Pain and Symptom Management, 30, 299-301. doi:10.1016/j.jpainsymman.2005.09.001
22. Kandel, D. B., & Logan, J. A. (1984). Patterns of drug use from adolescence to young adulthood: I. Periods of risk for initiation, continued use, and discontinuation. American Journal of Public Health, 74, 660-666. doi:10.2105/AJPH.74.7.660
23. Larochelle, M. R., Zhang, F., Ross-Degnan, D., & Wharam, J. F. (2015). Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene. JAMA Internal Medicine, 175, 978-987. doi:10.1001/jamainternmed.2015.0914
24. Lavonas, E. J., Severtson, S. G., Martinez, E. M., Bucher-Bartelson, B., Le Lait, M.-C., Green, J. L., Dart, R. C. (2014). Abuse and diversion of buprenorphine sublingual tablets and film. Journal of Substance Abuse Treatment, 47, 27-34. doi:10.1016/j.jsat.2014.02.003
25. Lawlor, J. (2015, January 23). Thousands of patients lose if state cuts methadone benefit. Portland Press Herald. Retrieved from http://www.pressherald.com/2015/01/23/thousands-of-patients-lose-if-state-cuts-methadone-benefit
26. Manchikanti, L., Fellows, B., Ailinani, H., & Pampati, V. (2010). Therapeutic use, abuse, and nonmedical use of opioids: A ten-year perspective. Pain Physician, 13, 401-435.
27. Martin, S. L., Baker, R. P., & Piper, B. J. (2015). Evaluation of urban-rural differences in pharmacy practice needs in Maine with the MaPPNA. Pharmacy Practice, 13, 669. doi:10.18549/PharmPract.2015.04.669
28. Martin, T. C., & Rocque, M. (2011). Accidental and non-accidental ingestion of methadone and buprenorphine in childhood: A single center experience, 1999-2009. Current Drug Safety, 6, 12-16. doi:10.2174/157488611794480034
29. Maxwell, J. C. (2011). The prescription drug epidemic in the United States: A perfect storm. Drug and Alcohol Review, 30, 264-270. doi:10.1111/j.1465-3362.2011.00291.x
30. McCall, K. L., 3rd, Tu, C., Lacroix, M., Holt, C., Wallace, K. L., & Balk, J. (2013). Controlled substance prescribing trends and physician and pharmacy utilization patterns: Epidemiological analysis of the Maine Prescription Monitoring Program from 2006 to 2010. Journal of Substance Use, 18, 467-475. doi:10.3109/14659891.2012.685794
31. Meier, B. (2013, June 11). Walgreen to pay 80 million fine in D.E.A. inquiry. The New York Times. Retrieved from http://www.nytimes.com/2013/06/12/business/walgreen-to-pay-80-million-settlement-over-painkiller-sales.html?_r=0
32. Norwood, C. W., & Wright, E. R. (2016). Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: Removing administrative barriers and increasing awareness of Rx drug abuse. Research in Social and Administrative Pharmacy, 12, 509-514. doi:10.1016/j.sapharm.2015.07.008
33. Patrick, S. W., Davis, M. M., Lehman, C. U., & Cooper, W. O. (2015). In-reasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology, 35, 650-655. doi: 10.1038/jp.2015.36. Erratum in Journal of Perinatology, 35, 667. doi:10.1038/jp.2015.63
34. Paul, J. A., Logan, B. A., Krishnan, R., Heller, N. A., Morrison, D. G., Pritham, U. A., Hayes, M. J. (2014). Development of auditory event-related potentials in infants prenatally exposed to methadone. Developmental Psychobiology, 56, 1119-1128. doi:10.1002/dev.21160
35. Paulozzi, L., Baldwin, G., & the Centers for Disease Control and Prevention (CDC). (2012). CDC grand rounds: Prescription drug overdoses - a U.S. epidemic. Morbidity and Mortality Weekly Report, 61, 10-13. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm
36. Paulozzi, L. J., Mack, K. A., & Hockenberry, J. M. (2014). Vital signs: Variation among states in prescribing opioid pain relievers and benzodiazepines - United States, 2012. Morbidity and Mortality Weekly Report, 63, 563-568. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6326a2.htm
37. Paulozzi, L. J., & Ryan, G. W. (2006). Opioid analgesics and rates of fatal drug poisoning in the United States. American Journal of Preventive Medicine, 31, 506-511. doi:10.1016/j.amepre.2006.08.017
38. Roche, T. (2000, December 31). The potent perils of a miracle drug. Time. Retrieved from http://content.time.com/time/magazine/article/0,9171,93319,00.html
39. Rosenberg, D. (2002, April 21). Oxy’s offspring. Newsweek. Retrieved from http://www.newsweek.com/oxys-offspring-142923
40. Russell, E. (2015, February 24). Judge strikes down Maine law allowing residents to buy drugs from foreign pharmacies. Portland Press Herald. Retrieved from http://www.pressherald.com/2015/02/24/maine-residents-cant-order-drugs-from-foreign-pharmacies-judge-rules/
41. Sansone, R. A., & Sansone, L. A. (2015). Buprenorphine treatment for narcotic addiction: Not without risks. Innovations in Clinical Neuroscience, 12, 32-36.
42. Smith, M. Y., Graham, J. A., Haddox, J. D., & Steffey, A. (2009). RxPA-TROL: A Web-based tool for combating pharmacy theft. Journal of the American Pharmacists Association, 49, 599-603. doi:10.1331/JAPhA.2009.08028
43. Sorg, M. H., & Greenwald, M. (2003). Patterns of drug-related mortality in Maine, 1997-2002. Maine Policy Review, 12, 84-96.
44. Turner, L., Kruszewski, S. P., & Alexander, G. C. (2015). Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013. American Journal on Addictions, 24, 24-29. doi:10.1111/ajad.12174
45. U.S. Census Bureau. (2010). Violent crime rate, 2007. Retrieved from https://www.census.gov/library/publications/2009/compendia/statab/129ed/rankings.html
46. U.S. Census Bureau. (2012, March 26). Growth in urban population out-paces rest of nation, Census Bureau reports. Retrieved from http://www.census.gov/newsroom/releases/archives/2010_census/cb12-50.html
47. Van Zee, A. (2009). The promotion and marketing of Oxycontin: Commercial triumph, public health tragedy. American Journal of Public Health, 99, 221-227. doi:10.2105/AJPH.2007.131714
48. Warner, M., Chen, L. H., Makuc, D. M., Anderson, R. N., & Miniño, A. M. (2011). Drug poisoning deaths in the United States, 1980-2008. NCHS data brief, no 81. Hyattsville, MD: National Center for Health Statistics
49. Weiner, S. G., Griggs, C. A., Langlois, B. K., Mitchell, P. M., Nelson, K. P., Friedman, F. D., & Feldman, J. A. (2015). Characteristics of emergency department “doctor shoppers.” The Journal of Emergency Medicine, 48, 424-431.e1. doi:10.1016/j.jemermed.2014.11.008
50. Wermeling, D. P. (2015). Review of naloxone safety for opioid over-dose: Practical considerations for new technology and expanded public access. Therapeutic Advances in Drug Safety, 6, 20-31. doi:10.1177/2042098614564776
51. Wright, E. R., Kooreman, H. E., Greene, M. S., Chambers, R. A., Banerjee, A., & Wilson, J. (2014b). The iatrogenic epidemic of prescription drug abuse: County-level determinants of opioid availability and abuse. Drug and Alcohol Dependence, 138, 209-215. doi:10.1016/j.drugalcdep.2014.03.002